Skip to main content

Ätiologie und Pathophysiologie des Fibromyalgiesyndroms

Aktualisierte Leitlinie 2017 und Übersicht von systematischen Übersichtsarbeiten sowie eine Übersicht über Studien zur Kleinfaserpathologie bei Subgruppen des FMS

Etiology and pathophysiology of fibromyalgia syndrome

Updated guidelines 2017, overview of systematic review articles and overview of studies on small fiber neuropathy in FMS subgroups

Zusammenfassung

Hintergrund

Die planmäßige Aktualisierung der S3-Leitlinie „Fibromyalgiesyndrom“, AWMF-Registernummer 145/004, war für April 2017 geplant.

Methodik

Die Leitlinie wurde unter Koordination der Deutschen Schmerzgesellschaft von dreizehn Fachgesellschaften und zwei Patientenselbsthilfeorganisationen entwickelt. Acht Arbeitsgruppen mit insgesamt 42 Mitgliedern wurden ausgewogen in Bezug auf Geschlecht, medizinischen Versorgungsbereich, potenzielle Interessenkonflikte und hierarchische Position im medizinischen bzw. wissenschaftlichen System besetzt. Die Literaturrecherche erfolgte über die Datenbanken MEDLINE, PsycINFO, Scopus und Cochrane Library (von Dezember 2010 bis Mai 2016). Es wurden prospektive bevölkerungsbasierte Studien und systematische Übersichten mit Metaanalysen von Fall-Kontroll-Studien für die Feststellungen berücksichtigt. Die Graduierung der Evidenzstärke erfolgte nach dem Schema des Oxford Centre for Evidence-Based Medicine, Version 2009. Die Formulierung der Feststellungen erfolgte in einem mehrstufigen, formalisierten Konsensusverfahren. Der Leitlinie wurde von den Vorständen der beteiligten Fachgesellschaften nach Überprüfung zugestimmt.

Ergebnisse

Die aktuelle Studienlage erlaubt keine eindeutigen Aussagen zur Ätiologie und Pathophysiologie des Fibromyalgiesyndroms (FMS). Das FMS kann mit entzündlich-rheumatischen Erkrankungen, Genpolymorphismen, Lebensstilfaktoren (Rauchen, Übergewicht, mangelnde körperliche Aktivität), körperlicher Misshandlung und sexuellem Missbrauch in Kindheit und Erwachsenenalter und depressiven Störungen assoziiert sein.

Schlussfolgerung

Das FMS ist wahrscheinlich die Endstrecke verschiedener ätiopathogenetischer Faktoren und pathophysiologischer Mechanismen.

Abstract

Background

The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was planned for April 2017.

Methods

The guidelines were developed by 13 scientific societies and 2 patient self-help organizations coordinated by the German Pain Society. Working groups (n =8) with a total of 42 members were formed balanced with respect to gender, medical expertise, position in the medical or scientific hierarchy and potential conflicts of interest. A systematic search of the literature from December 2010 to May 2016 was performed in the Cochrane library, MEDLINE, PsycINFO and Scopus databases. Prospective population-based studies and systematic reviews with meta-analyses of case control studies were taken into consideration for the statements. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine version 2009. The statements were generated by multiple step formalized procedures. The guidelines were reviewed and approved by the board of directors of the societies engaged in the development of the guidelines.

Results

Current data do not enable identification of distinct factors in the etiology and pathophysiology of fibromyalgia syndrome. Fibromyalgia syndrome can be associated with inflammatory rheumatic diseases, gene polymorphisms, life style factors (e.g. smoking, obesity and lack of physical activity), depressive disorders as well as physical and sexual abuse in childhood and adulthood.

Conclusion

Fibromyalgia syndrome is most probably the end result of various pathogenetic factors and pathophysiological mechanisms.

This is a preview of subscription content, access via your institution.

Literatur

  1. Afari N, Ahumada SM, Wright LJ, Mostoufi S, Golnari G, Reis V, Cuneo JG (2014) Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis. Psychosom Med 76:2–11

    Article  PubMed  Google Scholar 

  2. Aoki Y, Inokuchi R, Suwa H (2013) Reduced N‑acetylaspartate in the hippocampus in patients with fibromyalgia: a meta-analysis. Psychiatry Res 213:242–248

    CAS  Article  PubMed  Google Scholar 

  3. Cagnie B, Coppieters I, Denecker S, Six J, Danneels L, Meeus M (2014) Centralsensitization in fibromyalgia? A systematic review on structural and functionalbrain MRI. Semin Arthritis Rheum 44:68–75

    Article  PubMed  Google Scholar 

  4. Caro XJ, Winter EF (2014) Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications. Arthritis Rheumatol 66:1945–1954

    Article  PubMed  Google Scholar 

  5. Chang MH, Hsu JW, Huang KL, Su TP, Bai YM, Li CT, Yang AC, Chang WH, Chen TJ, Tsai SJ, Chen MH (2015) Bidirectional association between depression and fibromyalgia syndrome: a nationwide longitudinal study. J Pain 16:895–902

    Article  PubMed  Google Scholar 

  6. Cassisi G, Sarzi-Puttini P, Cazzola M (2011) Chronic widespread pain and fibromyalgia: could there be some relationships with infections and vaccinations? Clin Exp Rheumatol 6(Suppl 69):S118–S126

    Google Scholar 

  7. Clauw DJ (2014) Fibromyalgia: a clinical review. JAMA 311:1547–1555

    Article  PubMed  Google Scholar 

  8. Dehghan M, Schmidt-Wilcke T, Pfleiderer B, Eickhoff SB, Petzke F, Harris RE, Montoya P, Burgmer M (2016) Coordinate-based (ALE) meta-analysis of brain activation in patients with fibromyalgia. Hum Brain Mapp 37:1749–1758

    Article  PubMed  Google Scholar 

  9. de Tommaso M, Nolano M, Iannone F, Vecchio E, Ricci K, Lorenzo M, Delussi M, Girolamo F, Lavolpe V, Provitera V, Stancanelli A, Lapadula G, Livrea P (2014) Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features. J Neurol 261:461–472

    Article  PubMed  Google Scholar 

  10. Doppler K, Rittner HL, Deckart M, Sommer C (2015) Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia. Pain 156:2319–2325

    CAS  Article  PubMed  Google Scholar 

  11. Draheim N, Ebinger F, Schnöbel-Müller E, Wolf B, Häuser W (2017) Definition, Diagnostik und Therapie von chronischen Schmerzen in mehreren Körperregionen und des (sog.) Fibromyalgiesyndroms bei Kindern und Jugendlichen. Aktualisierte Leitlinie 2017. Schmerz 31. doi:10.1007/s00482-017-0208-z

  12. Forseth KO, Husby G, Gran JT, Førre O (1999) Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study. J Rheumatol 26:2458–2467

    CAS  PubMed  Google Scholar 

  13. Giannoccaro MP, Donadio V, Incensi A, Avoni P, Liguori R (2014) Small nerve fiber involvement in patients referred for fibromyalgia. Muscle Nerve 49:757–759

    Article  PubMed  Google Scholar 

  14. Häuser W, Bohn D, Kühn-Becker H, Erdkönig R, Brähler E, Glaesmer H (2012) Is the association of self-reported childhood maltreatments and adult fibromyalgia syndrome attributable to depression? A case control study. Clin Exp Rheumatol 30(6 Suppl 74):59–64

    PubMed  Google Scholar 

  15. Häuser W, Nothacker M (2017) Methodenreport der Leitlinie 2017 zum Fibromyalgiesyndrom. Schmerz 31. doi:10.1007/s00482-017-0209-y

    Google Scholar 

  16. Häuser W, Ablin J, Fitzcharles MA, Littlejohn J, Luciano JV, Usui C, Walitt B (2015) Fibromyalgia. Nat Rev Dis Primers 1:1522

    Google Scholar 

  17. Hsiao MY, Hung CY, Chang KV, Han DS, Wang TG (2015) Is serum hypovitaminosis D associated with chronic widespread pain including fibromyalgia? A meta-analysis of observational studies. Pain Physician 1:E877–E887

    Google Scholar 

  18. Kosmidis ML, Koutsogeorgopoulou L, Alexopoulos H, Mamali I, Vlachoyiannopoulos PG, Voulgarelis M, Moutsopoulos HM, Tzioufas AG, Dalakas MC (2014) Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled study. J Neurol Sci 347:143–147

    Article  PubMed  Google Scholar 

  19. Lee YC, Lu B, Boire G, Haraoui B, Hitchon CA, Pope JE, Thorne JC, Keystone EC, Solomon DH, Bykerk VB (2013) Incidence and predictors of secondary fibromyalgia in an early arthritis cohort. Ann Rheum Dis 72:949–954

    Article  PubMed  Google Scholar 

  20. Leinders M, Doppler K, Klein T, Deckart M, Rittner H, Sommer C, Üçeyler N (2016) Increased cutaneous miR-let-7d expression correlates with small nerve fiber pathology in patients with fibromyalgia syndrome. Pain 157:2493–2503

    CAS  Article  PubMed  Google Scholar 

  21. Martínez-Martínez LA, Mora T, Vargas A, Fuentes-Iniestra M, Martínez-Lavín M (2014) Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies. J Clin Rheumatol 20:146–150

    Article  PubMed  Google Scholar 

  22. Oaklander AL, Herzog ZD, Downs HM, Klein MM (2013) Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 154:2310–2316

    Article  PubMed  Google Scholar 

  23. Oudejans L, He X, Niesters M, Dahan A, Brines M, van Velzen M (2016) Cornea nerve fiber quantification and construction of phenotypes in patients with fibromyalgia. Sci Rep 6:23573

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. Ramírez M, Martínez-Martínez LA, Hernández-Quintela E, Velazco-Casapía J, Vargas A, Martínez-Lavín M (2015) Small fiber neuropathy in women with fibromyalgia. An in vivo assessment using corneal confocal bio-microscopy. Semin Arthritis Rheum 45:214–219

    Article  PubMed  Google Scholar 

  25. Rossi A, Di Lollo AC, Guzzo MP, Giacomelli C, Atzeni F, Bazzichi L, Di Franco M (2015) Fibromyalgia and nutrition: what news? Clin Exp Rheumatol 33(1 Suppl 88):S117–S125

    PubMed  Google Scholar 

  26. Serra J, Collado A, Solà R, Antonelli F, Torres X, Salgueiro M, Quiles C, Bostock H (2014) Hyperexcitable C nociceptors in fibromyalgia. Ann Neurol 75:196–208

    CAS  Article  PubMed  Google Scholar 

  27. Sommer C, Häuser W, Burgmer M, Engelhardt R, Gerhold K, Petzke F, Schmidt-Wilcke T, Späth M, Tölle T, Uçeyler N, Wang H, Winkelmann A, Thieme K, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (2012) Etiology and pathophysiology of fibromyalgia syndrome. Schmerz 26:259–267

    CAS  Article  PubMed  Google Scholar 

  28. Tak LM, Cleare AJ, Ormel J, Manoharan A, Kok IC, Wessely S, Rosmalen JG (2011) Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol Psychol 87:183–194

    Article  PubMed  Google Scholar 

  29. Üçeyler N, Zeller D, Kahn AK, Kewenig S, Kittel-Schneider S, Schmid A, Casanova-Molla J, Reiners K, Sommer C (2013) Small fibre pathology in patients with fibromyalgia syndrome. Brain 36:1857–1867

    Article  Google Scholar 

  30. Üçeyler N (2016) Small fiber pathology-a culprit for many painful disorders? Pain 157(Suppl 1):S60–S66

    Article  PubMed  Google Scholar 

  31. Walitt B, Ceko M, Gracely JL, Gracely RH (2016) Neuroimaging of central sensitivity syndromes: key insights from the scientific literature. Curr Rheumatol Rev 12:55–87

    Article  PubMed  PubMed Central  Google Scholar 

  32. Wolfe F, Häuser W, Walitt BT, Katz RS, Rasker JJ, Russell AS (2014) Fibromyalgia and physical trauma: the concepts we invent. J Rheumatol 41:1737–1745

    Article  PubMed  Google Scholar 

  33. Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Farber S, Prakash P, Ash J, Nowakowski J (2014) Long-term assessment of fibromyalgia in patients with culture-confirmed Lyme disease. Arthritis Rheumatol 67(3):837–839

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. Üçeyler.

Ethics declarations

Interessenkonflikt

Die Interessenkonflikte sind im Leitlinienreport [15] aufgeführt.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Üçeyler, N., Burgmer, M., Friedel, E. et al. Ätiologie und Pathophysiologie des Fibromyalgiesyndroms. Schmerz 31, 239–245 (2017). https://doi.org/10.1007/s00482-017-0202-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00482-017-0202-5

Schlüsselwörter

  • Fibromyalgiesyndrom
  • Leitlinie
  • Systematische Übersicht
  • Kleinfaserpathologie
  • Pathophysiologie

Keywords

  • Fibromyalgia syndrome
  • Guidelines
  • Review, systematic
  • Small fiber pathology
  • Pathophysiology